VIMMP facilitates and promotes the exchange between all materials modelling stakeholders for the benefit of increased innovation in European manufacturing industry. VIMMP will establish an open-source, user-friendly, powerful web-based marketplace linking beneficiaries from different manufacturing industry sectors with relevant materials modelling activities and resources. To enable a seamless and fully integrated environment, VIMMP is built on solid taxonomy and metadata foundations, including those centred on materials models, software tools, communities, translation expertise and training materials. VIMMP is a true marketplace, offering a substantial boost to all providers of tools and services; integrating modelling platforms based on Open Simulation Platform (OSP) standards that will be pursued in collaboration with the EMMC. Thus, any software owner can easily integrate models and certify codes to adhere to OSP standards. The Translator function will be supported by novel, collaborative tools that use metadata to combine models on an abstract logical level. OSP standards enable Translators and End User to build and deploy workflows quickly. VIMMP contributes novel avenues for coupling and linking of models, which will be validated in the context of three overlapping industry applications: personal goods, polymer nanocomposites and functional coatings. Data repositories relevant to modelling will be developed and integrated in VIMMP, including a novel input parameter repository for mesoscopic model, also materials properties and associated validation data. VIMMP will comprise a full set of education and training resources relevant for a wider range of manufacturing industry. VIMMP users will profit from lowering risk and upfront cost, greater speed and agility of deploying materials modelling and realising the wide range of demonstrated economic impacts.

The vision of the PICASO project is that it will become a Europe-wide Continuum of Care service platform that: will improve cooperation and exchange of knowledge between professional caregivers in health, rehabilitation and social care domains and actively include patients and their relatives in the integrated care settings thus supporting patient empowerment and self-care; will bring about improvements in health outcomes, daily activities, and quality of life of older persons with multi-morbidities by personalising care management programmes to specific characteristics of the patients' profiles and support adherence to care plans at the point of need; will reinforced medical knowledge and create new care models for management and treatment of patients with multi-morbidity conditions; will allow more cost-effective care management through increased skills and collaboration of care professionals and more automated and efficient workflows, which eventually will lead to better health outcome and a reduction in hospitals admissions, and thus contributing significantly to the sustainability of health and social care systems in Europe.

Soft Matter is ubiquitous, in the form of polymers, colloids, gels, foams, emulsions, pastes, or liquid crystals; of synthetic or biological origin; as bulk materials or as thin films at interfaces. Soft Matter impinges on almost every aspect of human activity: what we eat, what we wear, the cars we drive, the medicines we take, what we use to keep clean and healthy, in sport and leisure. Soft Matter plays a role in many industrial processes including new frontiers such as digital manufacturing, regenerative medicine and personalised products. Soft Matter is complex chemically and physically with structure and properties that depend on length and time scales. Too often the formulation of soft materials has been heuristic, without the fundamental understanding that underpins predictive design, which hampers innovation and leads to problems in scale up and reformulation in response to changing regulation or customer preferences. Durham, Edinburgh and Leeds Universities set up the SOFI CDT in 2014 in response to the challenge from manufacturers across the personal care, coatings, plastics and food sectors to provide future employees with the skills to transform the design and manufacture of soft materials from an art into a science. The dialogue continues with industrial partners, both old and new, which has resulted in this bid for a refreshed CDT in Soft Matter - SOFI2 - that reflects the evolving scientific, technological and industrial landscape. We have a new partnership with the National Formulation Centre, who will lead a training case study and contribute to the wider training programme, and with many new partners from SMEs to multinationals. We will seek to involve more small and medium-sized companies in SOFI2 by providing opportunities for them to engage in training and project supervision. SOFI2 will have increased training in biological soft matter, which has been identified as a growth area by the EPSRC and our partners, and in scale-up and manufacturing, so that our students can understand better the challenges of taking ideas from the laboratory to the customer. Social responsibility in research and innovation will be embedded throughout the training program and we will trial new ideas in participatory research where the public is involved in the creation of research projects. Each cohort of 16 students will spend their first six months on a common training programme in science and engineering, built around case studies co-delivered with industry partners. They then select their PhD projects and join their research groups in Durham, Leeds or Edinburgh. Generic and transferable skills training continues throughout the four years, bringing the cohorts together for both academic-led and student-led activities. We aim to produce SOFI2 graduates who are business-aware and who are good citizens as well as good scientists. The importance of Soft Matter to the UK economy cannot be understated. Industry sectors relying on Soft Matter include paints and coatings; adhesives, sealants and construction products; rubber, plastics and composite materials; pharmaceuticals and healthcare; cosmetics and personal care; household and professional care; agrochemicals; food and beverages; inks and dyes; lubricants and fuel additives; and process chemicals. A 2018 InnovateUK report estimate the formulated products sector (most of which involves Soft Matter) contributed £149 billion annually to the UK economy. The formulated products sector is undergoing a rapid transformation in response to a shift to sustainable feedstocks, environmental and regulatory pressures and personalised products. It will also be shaped in unpredictable ways by data analytics and artificial intelligence. SOFI2 will equip students with the knowledge and skills to thrive in this business environment.

Chronic diseases are now the leading causes of death in both developing and developed countries. Such conditions include diabetes, asthma, arthritis, heart failure, COPD, dementia and a range of disabling psychological conditions such as depression. In the UK the cost of care of people with chronic conditions consumes the majority of health and social care resources, for example, accounting for over 80% of GP consultations. While the UK and India have very different practices and structures for healthcare delivery, the effective management of chronic illness is a priority for both countries. Patients in rural areas, however, present particular challenges that neither country's healthcare systems are well configured to address. This issue is particularly relevant to India with 71% of the population in rural areas. While less than 1 in 5 of the UK population are rural dwellers, large parts of the country are sparsely populated; for example in Scotland, 29% of the population live in rural areas. Rural healthcare inequality in both countries arises from a number of factors, including transport costs and the inaccessibility of specialist services. The goal of the TRUMP project is to explore the potential of mobile technologies in the development of a platform to support chronic disease management by simultaneously considering the needs of rural areas of India and the UK. Trust in such systems is vital if they are be accepted by patients and health workers alike, and this issue will form a central part of the development of the platform. Two common chronic conditions, diabetes and depression, have been chosen as exemplars for the development of the platform and its evaluation. TRUMP is a multidisciplinary project involving academic researchers from the UK and India, together with partner organisations drawn from the business and community sectors. Working together, this team will: perform a detailed analysis of the healthcare context, design sustainable technology solutions compatible with local and national healthcare policies; incorporate existing proven chronic management programmes and training. This implies support for novel patient record systems, mechanisms for tracking the patient (symptoms and behaviour), as well as patient awareness of self-management.